Publication | Closed Access

Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus

Metabolic SyndromeHealth SciencesBiochemistryMitochondrial FunctionMitochondrial DysfunctionLiver PhysiologyDiabetesPhysiologyMedicineDiabetes MellitusDapagliflozin ProtectsMetabolomicsMetabolismPharmacologyFatty Liver DiseaseInsulin SignalingOxidative StressChronic Treatment